- •
Esophageal reflux monitoring, although helpful in the diagnostic assessment of gastroesophageal reflux disease, has its limitations and should be used as a supporting component in the diagnosis.
- •
Not all reflux events cause symptoms, and not all symptoms are caused by reflux.
- •
Acid reflux is uncommon while on proton pump inhibitor (PPI) therapy; thus, pH monitoring without impedance may have limited usefulness if performed on patients on PPIs.
- •
Detection of nonacid reflux may be helpful
Acid and Nonacid Reflux Monitoring
Section snippets
Key points
Indications for esophageal reflux monitoring
Esophageal reflux monitoring can be used to support a diagnosis of GERD, such as before antireflux procedures, or when the diagnosis of GERD may be in question, such as when there is a lack of response to effective therapy. After an empirical trial of acid suppression therapy, generally with proton pump inhibitors (PPIs), upper endoscopy is the initial diagnostic test performed, because it can assess for complications (especially if patients show alarm symptoms, eg, dysphagia) and also confirm
Performance of esophageal reflux monitoring
Once the decision to pursue reflux monitoring has been made, the next step is to choose which type of device to use (Fig. 1): pH monitoring, either catheter-based (conventional) or wireless (Bravo pH monitoring system, Given Imaging, Yoqneam, Israel), or impedance pH. The basic equipment needed to perform any type of reflux monitoring includes a portable data logger, the sensor (pH or impedance pH), a computer, and analysis software.
There are also tests available to measure gastroduodenal or
Test interpretation
pH measurements from the distal esophagus are reported in terms of the percent time at abnormal pH (pH <4) and the number of reflux events (Fig. 3). In addition to detecting retrograde liquid reflux events, impedance studies also qualify reflux events in terms of pH: acid (pH <4) or nonacid (pH ≥4) (Fig. 4). Patient-provided data entered into the data logger can be used for symptom-reflux association analysis. Data can also be incorporated into a composite score (the Demeester score), which
Summary
When applied and interpreted appropriately, esophageal reflux monitoring is an important component in the armamentarium for the diagnosis of GERD. In the absence of specific endoscopic findings, a confident diagnosis of GERD based on the detection of reflux of gastric contents that causes troublesome symptoms can be challenging. Reflux monitoring can detect refluxed contents, both acid and nonacid (if impedance is incorporated), and causality of troublesome symptoms can be inferred from the
References (73)
- et al.
Predictors of outcome in 100 consecutive laparoscopic antireflux procedures
Am J Surg
(2001) - et al.
Limited ability of the proton-pump inhibitor test to identify patients with gastroesophageal reflux disease
Clin Gastroenterol Hepatol
(2012) - et al.
Preoperative diagnostic workup before antireflux surgery: an evidence and experience-based consensus of the esophageal diagnostic advisory panel
J Am Coll Surg
(2013) - et al.
Twenty-four-hour esophageal pH monitoring: the most useful test for evaluating noncardiac chest pain
Am J Med
(1991) - et al.
Ambulatory esophageal pH monitoring using a wireless system
Am J Gastroenterol
(2003) - et al.
Four-day Bravo pH capsule monitoring with and without proton pump inhibitor therapy
Clin Gastroenterol Hepatol
(2005) - et al.
Batteryless implantable dual-sensor capsule for esophageal reflux monitoring
Gastrointest Endosc
(2013) - et al.
Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole
Gastroenterology
(2001) - et al.
Efficacy of esophageal impedance/pH monitoring in patients with refractory gastroesophageal reflux disease, on and off therapy
Clin Gastroenterol Hepatol
(2009) - et al.
Clinical esophageal pH recording: a technical review for practice guideline development
Gastroenterology
(1996)
Optimal thresholds, sensitivity, and specificity of long-term pH-metry for the detection of gastroesophageal reflux disease
Gastroenterology
Bravo catheter-free pH monitoring: normal values, concordance, optimal diagnostic thresholds, and accuracy
Clin Gastroenterol Hepatol
Normal values of pharyngeal and esophageal 24-hour pH impedance in individuals on and off therapy and interobserver reproducibility
Clin Gastroenterol Hepatol
The symptom-association probability: an improved method for symptom analysis of 24-hour esophageal pH data
Gastroenterology
Acoustic cough-reflux associations in chronic cough: potential triggers and mechanisms
Gastroenterology
The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus
Am J Gastroenterol
Burden of gastrointestinal disease in the United States: 2012 update
Gastroenterology
Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux
Gut
American Gastroenterological Association Institute technical review on the management of gastroesophageal reflux disease
Gastroenterology
Esophageal-reflux monitoring
Gastrointest Endosc
ACG practice guidelines: esophageal reflux testing
Am J Gastroenterol
Diagnostic and therapeutic use of proton pump inhibitors in non-cardiac chest pain: a metaanalysis
Am J Gastroenterol
Response of unexplained chest pain to proton pump inhibitor treatment in patients with and without objective evidence of gastro-oesophageal reflux disease
Gut
Guidelines for the diagnosis and management of gastroesophageal reflux disease
Am J Gastroenterol
Duodenogastroesophageal reflux and methods to monitor nonacidic reflux
Am J Med
The relationship between acid and bile reflux and symptoms in gastro-oesophageal reflux disease
Gut
Effect of omeprazole 20 mg twice daily on duodenogastric and gastro-oesophageal bile reflux in Barrett's oesophagus
Gut
Influence of pantoprazole on oesophageal motility, and bile and acid reflux in patients with oesophagitis
Aliment Pharmacol Ther
Intra-esophageal pH probe movement during eating and talking. A videoradiographic study
Acta Radiol
Studies of acid exposure immediately above the gastro-oesophageal squamocolumnar junction: evidence of short segment reflux
Gut
Comparison of esophageal acid exposure at 1 cm and 6 cm above the squamocolumnar junction using the Bravo pH monitoring system
Dis Esophagus
Safety and tolerability of transoral Bravo capsule placement after transnasal manometry using a validated conversion factor
Am J Gastroenterol
Feasibility and tolerability of transnasal/per-oral placement of the wireless pH capsule vs. traditional 24-h oesophageal pH monitoring–a randomized trial
Aliment Pharmacol Ther
Nonendoscopic transnasal placement of a wireless capsule for esophageal pH monitoring: feasibility, safety, and efficacy of a manometry-guided procedure
Endoscopy
Appropriate acid suppression for the management of gastro-oesophageal reflux disease
Digestion
Antireflux surgery in patients with chronic cough and abnormal proximal exposure as measured by hypopharyngeal multichannel intraluminal impedance
JAMA Surg
Cited by (4)
The Mexican consensus on non-cardiac chest pain
2019, Revista de Gastroenterologia de MexicoThe management of gastro-oesophageal reflux disease
2016, Australian PrescriberSafety, tolerability, pharmacokinetics, and pharmacodynamics of single rising Tak-438 (Vonoprazan) doses in healthy male Japanese/Non-Japanese Subjects
2015, Clinical and Translational Gastroenterology
Disclosures: Given Imaging (speaker, consultant), Astra Zeneca (speaker) (J.E. Pandolfino); none (D.A. Carlson).